利用结肠分子谱评估嗜酸性结肠炎为独立疾病:一项多中心研究
本研究纳入嗜酸性结肠炎(EoC)27例、正常对照20例和克罗恩病(CD)14例,对结肠活检行RNA测序。EoC与正常结肠之间有987个差异表达基因,EoC转录组评分可随疾病缓解而逆转,并能将EoC与炎症性肠病(IBD)区分。研究认为EoC是区别于其他嗜酸性胃肠道疾病(EGIDs)和IBD的独立疾病。
要点
- EoC诊断标准为升结肠≥100、降结肠≥85、乙状结肠≥65个嗜酸性粒细胞/高倍视野并伴相关症状。
- EoC与正常结肠间有987个差异表达基因(变化倍数>1.5,P<.05)。
- EoC转录组评分随疾病缓解而逆转,并可区分EoC与IBD(P<.0001)。
核心结论
- 研究建立了EoC的转录组谱并识别了机制通路,认为EoC是区别于其他EGIDs和IBD的独立疾病,为改进诊断和治疗提供了基础。
研究设计与样本
- 多中心研究纳入EoC患者27例、正常对照20例和克罗恩病14例,对结肠活检组织行RNA测序。
主要发现
- EoC与正常结肠之间鉴定出987个差异表达基因(变化倍数>1.5,P<.05)。
- 结肠嗜酸性粒细胞计数与31%的EoC转录组相关,其中与CCL11和CLC相关性最显著(r=0.78和0.77,P<.0001)。
- EoC与其他EGIDs之间转录组重叠极少,且EoC中缺乏强过敏型2型免疫反应的证据。
- 功能富集分析和Ki-67、cleaved caspase-3免疫染色显示,EoC较正常对照细胞周期减少、凋亡增加。
- 腺周环状嗜酸性粒细胞袖套与EoC转录组相关(P<.001)。
关键数值与推荐
- EoC诊断标准:升结肠≥100、降结肠≥85、乙状结肠≥65个嗜酸性粒细胞/高倍视野,并伴相关症状。
- 差异表达基因筛选标准:变化倍数>1.5且P<.05。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Colonic eosinophilia, an enigmatic finding often referred to as eosinophilic colitis (EoC), is a poorly understood condition. Whether EoC is a distinct disease or a colonic manifestation of eosinophilic gastrointestinal diseases (EGIDs) or inflammatory bowel disease (IBD) is undetermined. METHODS: Subjects with EoC (n = 27) and controls (normal [NL, n = 20], Crohn's disease [CD, n = 14]) were enrolled across sites associated with the Consortium of Eosinophilic Gastrointestinal Disease Researchers. EoC was diagnosed as colonic eosinophilia (ascending ≥100, descending ≥85, sigmoid ≥65 eosinophils/high-power field) with related symptoms. Colon biopsies were subjected to RNA sequencing. Associations between gene expression and histologic features were analyzed with Spearman correlation; operational pathways and cellular constituents were computationally derived. RESULTS: We identified 987 differentially expressed genes (EoC transcriptome) between EoC and NL (>1.5-fold change, P < .05). Colonic eosinophil count correlated with 31% of EoC transcriptome, most notably with CCL11 and CLC (r = 0.78 and 0.77, P < .0001). Among EoC and other EGIDs, there was minimal transcriptomic overlap and minimal evidence of a strong allergic type 2 immune response in EoC compared with other EGIDs. Decreased cell cycle and increased apoptosis in EoC compared with NL were identified by functional enrichment analysis and immunostaining using Ki-67 and cleaved caspase-3. Pericryptal circumferential eosinophil collars were associated with the EoC transcriptome (P < .001). EoC transcriptome-based scores were reversible with disease remission and differentiated EoC from IBD, even after controlling for colonic eosinophil levels (P < .0001). CONCLUSIONS: We established EoC transcriptomic profiles, identified mechanistic pathways, and integrated findings with parallel IBD and EGID data. These findings establish EoC as a distinct disease compared with other EGIDs and IBD, thereby providing a basis for improving diagnosis and treatment.
引用
- Shoda T, Collins MH, Rochman M, et al. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022. PMID: 35085569. doi:10.1053/j.gastro.2022.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。